UmanDiagnostics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$22.5M
UmanDiagnostics General Information
Description
Manufacturer of biomarker products designed for the detection of neurological injuries. The company offers serum elisa assays, cerebrospinal fluid elisa kits, monoclonal antibodies, research use only products, clinical diagnostic tools, and biomarker solutions, providing researchers and diagnostic companies with tools for the quantification of neurofilament light protein to identify neuronal damage.
Contact Information
Website
www.umandiagnostics.com(Operating Subsidiary)
Corporate Office
- Tvistevägen 48 C
- 907 36 Umea
- Sweden
Corporate Office
- Tvistevägen 48 C
- 907 36 Umea
- Sweden
UmanDiagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Aug-2019 | $22.5M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 12-Apr-2006 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
UmanDiagnostics Comparisons
Industry
Financing
Details
UmanDiagnostics Competitors (26)
One of UmanDiagnostics’s 26 competitors is Diagenode, a Formerly VC-backed company based in Seraing, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Diagenode | Formerly VC-backed | Seraing, Belgium | ||||
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| Aviva Systems Biology | Formerly VC-backed | San Diego, CA | ||||
| StressMarq Biosciences | Corporation | Victoria, Canada | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO |
UmanDiagnostics Signals
UmanDiagnostics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovationsbron | Venture Capital | Minority | ||
| Inro Biomedtek | Corporation | Minority | ||
| Norrlandsfonden | Lender/Debt Provider | Minority | ||
| Umeå Biotech Incubator | Accelerator/Incubator | Minority | ||
| Uminova Invest | Venture Capital | Minority |
UmanDiagnostics FAQs
-
When was UmanDiagnostics founded?
UmanDiagnostics was founded in 2006.
-
Where is UmanDiagnostics headquartered?
UmanDiagnostics is headquartered in Umea, Sweden.
-
What is the size of UmanDiagnostics?
UmanDiagnostics has 10 total employees.
-
What industry is UmanDiagnostics in?
UmanDiagnostics’s primary industry is Diagnostic Equipment.
-
Is UmanDiagnostics a private or public company?
UmanDiagnostics is a Private company.
-
What is the current valuation of UmanDiagnostics?
The current valuation of UmanDiagnostics is .
-
What is UmanDiagnostics’s current revenue?
The current revenue for UmanDiagnostics is .
-
Who are UmanDiagnostics’s investors?
Innovationsbron, Inro Biomedtek, Norrlandsfonden, Umeå Biotech Incubator, and Uminova Invest have invested in UmanDiagnostics.
-
Who are UmanDiagnostics’s competitors?
Diagenode, BioGenex Laboratories, Aviva Systems Biology, StressMarq Biosciences, and Novus Biologicals are some of the 26 competitors of UmanDiagnostics.
-
When was UmanDiagnostics acquired?
UmanDiagnostics was acquired on 01-Aug-2019.
-
Who acquired UmanDiagnostics?
UmanDiagnostics was acquired by Quanterix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process